🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase 1b/2 study to evaluate the safety and efficacy of metronomi...
Status
Terminated
Location
Chan Soon-Shiong Institute for Medicine
Start Date
2018-01-09
Trial ID
NCT03387111
The proposed clinical trial is a phase I, open-label, multi-center, dose-es...
Status
Completed
Location
University of Minnesota
Start Date
2014-05
Trial ID
NCT01946789
Treatments Being Tested
This phase IIb trial tests whether Tri-Ad5 in combination with N-803 works ...
Status
Active Not Recruiting
Location
Mayo Clinic Hospital in Arizona
Start Date
2023-05-08
Trial ID
NCT05419011
Open-label, Phase 1 Study of CD19 t-haNK as a Single Agent and in Combinati...
Status
Recruiting
Location
Hoag Memorial Hospital
Start Date
2025-08-22
Trial ID
NCT05618925
Treatments Being Tested
Non-interventional PK sub-study of QUILT-3.032 (CA-ALT-803-01-16) and QUILT...
Status
Terminated
Location
UCLA Department of Urology
Start Date
2019-12-09
Trial ID
NCT04142359
Treatments Being Tested
The purpose of this clinical trial is to obtain long-term follow-up informa...
Status
Active Not Recruiting
Location
Island Urology
Start Date
2023-08-17
Trial ID
NCT05981131
Treatments Being Tested
This phase Ib trial will investigate the effect of N-803 in combination wit...
Status
Withdrawn
Location
Multiple Locations
Start Date
2026-02-15
Trial ID
NCT07217496
This is a phase 1b/2 study to evaluate the safety and efficacy of metronomi...
Status
Withdrawn
Location
Chan Soon-Shiong Institute for Medicine
Start Date
2018-05-25
Trial ID
NCT03563170
The study participant is being asked to take part in this research study be...
Status
Recruiting
Location
University of California San Francisco
Start Date
2025-11-10
Trial ID
NCT07085338
Treatments Being Tested
Phase 2, single-arm study to evaluate combination therapy of avelumab, haNK...
Status
Terminated
Location
University of California San Francisco
Start Date
2020-02-19
Trial ID
NCT03853317